STAAR Surgical Company reports results for the quarter ended September 30 - Earnings Summary

• STAAR Surgical Company reported quarterly adjusted earnings of 11 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 18 cents. The mean expectation of ten analysts for the quarter was for earnings of 6 cents per share. Wall Street expected results to range from -4 cents to 12 cents per share.

• Revenue fell 12% to $83.41 million from a year ago; analysts expected $78.76 million.

• STAAR Surgical Company's reported EPS for the quarter was 11 cents​.

• The company reported quarterly net income of $5.58 million.

• STAAR Surgical Company shares had risen by 11.3% this quarter and gained 9.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 20.6% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for STAAR Surgical Company is $27.00, about 6.8% above its last closing price of $25.17

This summary was machine generated from LSEG data November 4 at 10:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)